4 research outputs found
Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial
BACKGROUND: Emergency abdominal surgery is associated with poor patient outcomes. We studied the effectiveness of a national quality improvement (QI) programme to implement a care pathway to improve survival for these patients. METHODS: We did a stepped-wedge cluster-randomised trial of patients aged 40 years or older undergoing emergency open major abdominal surgery. Eligible UK National Health Service (NHS) hospitals (those that had an emergency general surgical service, a substantial volume of emergency abdominal surgery cases, and contributed data to the National Emergency Laparotomy Audit) were organised into 15 geographical clusters and commenced the QI programme in a random order, based on a computer-generated random sequence, over an 85-week period with one geographical cluster commencing the intervention every 5 weeks from the second to the 16th time period. Patients were masked to the study group, but it was not possible to mask hospital staff or investigators. The primary outcome measure was mortality within 90 days of surgery. Analyses were done on an intention-to-treat basis. This study is registered with the ISRCTN registry, number ISRCTN80682973. FINDINGS: Treatment took place between March 3, 2014, and Oct 19, 2015. 22â754 patients were assessed for elegibility. Of 15â873 eligible patients from 93 NHS hospitals, primary outcome data were analysed for 8482 patients in the usual care group and 7374 in the QI group. Eight patients in the usual care group and nine patients in the QI group were not included in the analysis because of missing primary outcome data. The primary outcome of 90-day mortality occurred in 1210 (16%) patients in the QI group compared with 1393 (16%) patients in the usual care group (HR 1·11, 0·96-1·28). INTERPRETATION: No survival benefit was observed from this QI programme to implement a care pathway for patients undergoing emergency abdominal surgery. Future QI programmes should ensure that teams have both the time and resources needed to improve patient care. FUNDING: National Institute for Health Research Health Services and Delivery Research Programme
Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial
Background: Emergency abdominal surgery is associated with poor patient outcomes. We studied the effectiveness of a national quality improvement (QI) programme to implement a care pathway to improve survival for these patients. Methods: We did a stepped-wedge cluster-randomised trial of patients aged 40 years or older undergoing emergency open major abdominal surgery. Eligible UK National Health Service (NHS) hospitals (those that had an emergency general surgical service, a substantial volume of emergency abdominal surgery cases, and contributed data to the National Emergency Laparotomy Audit) were organised into 15 geographical clusters and commenced the QI programme in a random order, based on a computer-generated random sequence, over an 85-week period with one geographical cluster commencing the intervention every 5 weeks from the second to the 16th time period. Patients were masked to the study group, but it was not possible to mask hospital staff or investigators. The primary outcome measure was mortality within 90 days of surgery. Analyses were done on an intention-to-treat basis. This study is registered with the ISRCTN registry, number ISRCTN80682973. Findings: Treatment took place between March 3, 2014, and Oct 19, 2015. 22 754 patients were assessed for elegibility. Of 15 873 eligible patients from 93 NHS hospitals, primary outcome data were analysed for 8482 patients in the usual care group and 7374 in the QI group. Eight patients in the usual care group and nine patients in the QI group were not included in the analysis because of missing primary outcome data. The primary outcome of 90-day mortality occurred in 1210 (16%) patients in the QI group compared with 1393 (16%) patients in the usual care group (HR 1·11, 0·96â1·28). Interpretation: No survival benefit was observed from this QI programme to implement a care pathway for patients undergoing emergency abdominal surgery. Future QI programmes should ensure that teams have both the time and resources needed to improve patient care. Funding: National Institute for Health Research Health Services and Delivery Research Programme
Unicystic ameloblastoma mimicking a dentigerous cyst: short case report
Observation: This case reports an unusual morphology and localisation of ameloblastoma that imitates a dentigerous cyst on an inclused mandibular canine. Comments: Ameloblastoma is a local odontogenic benign tumour which often relapse. It is usually described in its polycystic form in the posterior mandibular part
ThrombasthĂ©nie de Glanzmann et avulsions dentaires : Ă propos dâun cas
Introduction : La thrombasthénie de Glanzmann est une maladie congénitale
rare et sĂ©vĂšre de lâhĂ©mostase primaire. Elle se caractĂ©rise par un dĂ©faut dâagrĂ©gation
plaquettaire pouvant entraßner des hémorragies majeures. Elle se transmet sous le mode
autosomique récessif. Les patients atteints nécessitent une prise en charge
multidisciplinaire lors dâun acte chirurgical. Observation : Il sâagissait
dâune femme de 20 ans adressĂ©e pour avulsion de 18, 28 et 48 enclavĂ©e avec des Ă©pisodes de
péricoronarites récidivants. Elle présentait une thrombasthénie de Glanzmann depuis
lâenfance. Elle rapportait deux Ă©pisodes hĂ©morragiques sĂ©vĂšres depuis le diagnostic. Le
bilan dâhĂ©mostase prĂ©opĂ©ratoire a rapportĂ© une Hb Ă 11 g/dL, des plaquettes Ă 380 000 g/L,
un TCA et un TQ/TP normaux mais un PFA fortement allongé (>100 secondes). AprÚs avis de
lâhĂ©matologue, le protocole suivant a Ă©tĂ© adoptĂ©Â : hospitalisation traditionnelle (48 h),
choix dâune anesthĂ©sie gĂ©nĂ©rale avec intubation naso-trachĂ©ale, perfusion IV de rFVIIa
(NovosevenÂź) 30Â minutes avant lâacte chirurgical puis 2Â heures aprĂšs, 3Â grammes dâacide
tranexamique (ExacylÂź) IV puis per os et en bain de bouche. LâhĂ©mostase chirurgicale a
associĂ© des sutures Ă lâutilisation dâoxycellulose (SurgicelÂź) et de colle de fibrine
(TissucolŸ) dans les alvéoles et sur les sutures. Les avulsions se sont déroulées sans
accident hémorragique per- et postopératoire. Discussion : La thromboasthénie
de Glanzmann fait partie des thrombopathies affectant lâagrĂ©gation plaquettaire et il en
existe deux types. Le diagnostic de certitude repose sur des examens biologiques et une
étude génétique. En cas de chirurgie programmée, le médecin référent doit établir un
protocole personnalisé en fonction du risque hémorragique du patient. Les traitements
hémostatiques par voie générale à disposition sont les transfusions de concentrés
plaquettaires ou de facteur VII activé recombinant (NovosevenŸ). Si le patient présente
une allo- ou une iso-immunisation liĂ©e aux transfusions plaquettaires, lâutilisation de
rFVIIa est recommandée. Conclusion : Le rÎle du chirurgien oral est crucial
dans la prise en charge de ces patients. Outre la procédure de substitution hématologique,
lâefficacitĂ© de lâhĂ©mostase chirurgicale est conditionnĂ©e par une bonne gestion des
risques de saignement per- et postopératoire